A performance evaluation of sthemO 301 coagulation analyzer and associated reagents
Journal of Clinical Laboratory Analysis · 2023
DOI: 10.1002/jcla.24929 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Clinical Laboratory Analysis, 2023. Verfasst von Adeline Pontis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire d'Hématologie-Hémostase, Centre Hospitalo-Universitaire de Rennes Pontchaillou, Rennes, France. Hauptthemen laut MEDLINE: Blood Coagulation Tests, Laboratories, Clinical. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diagnostica Stago SAS.
Abstract (Originalsprache)
Aim
The study objective was to evaluate the performance of sthemO 301 system and to compare it with the analyzer used in our university hospital laboratory (STA R Max® 2), for a selection of hemostasis parameters.
Methods
Method comparison (according to CLSI EP09‐A3), carryover (according to CLSI H57‐A), APTT sensitivity to heparin (according to CLSI H47‐A2), HIL level assessment, and productivity were performed using leftover samples from our laboratory ( n > 1000). Commercial quality control materials were used to evaluate precision (according to CLSI EP15‐A3) and accuracy. The assays tested on sthemO 301 were: PT, APTT (silica and kaolin activators), fibrinogen (Fib), thrombin time (TT), chromogenic and clotting protein C (PC) activity, and von Willebrand factor antigen (VWF:Ag) levels.
Results
All intra‐assay and inter‐assay precision CVs were below the maximal precision limit proposed by the French Group for Hemostasis and Thrombosis (GFHT). Accuracy was verified with bias below GFHT criteria and most Z‐scores were between −2 and +2. No clinically relevant carryover was detected. Silica APTT reagent sensitivity to unfractionated heparin was moderate, as expected. Productivity results were consistent over the 10 repeats performed. The overall agreement between the two systems was excellent for all assays, with Spearman rank correlation coefficient all above 0.9 and slopes of Passing–Bablok correlation near 1 and intercepts close to 0.
Conclusion
For the methods tested, sthemO 301 system met all the criteria to implement a novel coagulation analyzer in the laboratory and result comparability with STA R Max® 2 was good.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire d'Hématologie-Hémostase, Centre Hospitalo-Universitaire de Rennes Pontchaillou, Rennes, France.
- INSERM, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, Université de Rennes, Rennes, France.
- Diagnostica Stago, Asnières-sur-Seine, France.
ORCID-Profile: Adeline Pontis, Audrey Carlo
Förderung
- Diagnostica Stago SAS
Zitieren
APA
Pontis, A., Delanoe, M., Schilliger, N., Carlo, A., Guéret, P., Nédélec-Gac, F., & Gouin-Thibault, I. (2023). A performance evaluation of sthemO 301 coagulation analyzer and associated reagents. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.24929
Vancouver
Pontis A, Delanoe M, Schilliger N, Carlo A, Guéret P, Nédélec-Gac F, et al. A performance evaluation of sthemO 301 coagulation analyzer and associated reagents. Journal of Clinical Laboratory Analysis. 2023. doi:10.1002/jcla.24929
BibTeX
@article{Pontis2023,
author = {Pontis, Adeline and Delanoe, Mélanie and Schilliger, Nathalie and Carlo, Audrey and Guéret, Pierre and Nédélec-Gac, Fabienne and Gouin-Thibault, Isabelle},
title = {A performance evaluation of sthemO 301 coagulation analyzer and associated reagents},
journal = {Journal of Clinical Laboratory Analysis},
year = {2023},
doi = {10.1002/jcla.24929}
}
EUVIMED